Copeland J G, Griepp R B, Bieber C P, Billingham M, Schroeder J S, Hunt S, Mason J, Stinson E B, Shumway N E
J Thorac Cardiovasc Surg. 1977 Feb;73(2):242-7.
Cardiac retransplantation has been performed in five patients at Stanford University Medical Center. Long-term survival and rehabilitation have been achieved in two cases. In the first case retransplantation was performed 57 days after the initial procedure because of persistent acute graft rejection. The second patient underwent retransplantation 27 months postoperatively because of documented accelerated graft atherosclerosis. The major indications for cardiac retransplantation consist of intractable acute rejection and late postoperative graft atherosclerosis. These complications should prompt consideration of cardiac retransplantation in carefully selected cases.
斯坦福大学医学中心已对5名患者进行了心脏再次移植手术。其中2例患者实现了长期存活并康复。第一例患者在初次手术后57天因持续性急性移植物排斥反应而进行了再次移植。第二例患者在术后27个月因有记录的加速性移植物动脉粥样硬化而接受了再次移植。心脏再次移植的主要指征包括难治性急性排斥反应和术后晚期移植物动脉粥样硬化。在经过精心挑选的病例中，这些并发症应促使考虑进行心脏再次移植。
